-
Norway, in mourning, enters a new era under King Haakon VIII
-
Mourinho says Mbappe worthy of Ballon d'Or
-
Rain frustrates England's bid for Pakistan series win
-
Clashes rock Niger capital, junta says back in control
-
Rafael Leao leaving AC Milan for Galatasaray
-
India's Neeraj Chopra out for season with ankle injury
-
Bhim Army Protesters and Police Scuffle During Patna BPSC March
-
Karnataka Rules Out Smaller Mysuru Dasara Despite Drought
-
BJP Leadership Reviews Youth Outreach and Seven State Elections
-
TVK Legislator’s Jallikattu Criticism Draws Demand for Party Clarification
-
Omitted Social Justice Figures Trigger Dispute Over Tamil Nadu Policy Note
-
SUV Tyre Failure Kills Three Chennai College Students
-
Suspect Arrested in Manipur After Body Found on Tamil Nadu Express
-
Three Students Die, Four Injured in Madurantakam Car Crash
-
Celebrities Share Late-Summer Photos in August Gallery
-
Ray J Open to Settling Blueface Dispute in Paid Boxing Match
-
Judge Grants Brittany Cartwright Temporary Restraining Order Against Jax Taylor
-
Influencers Agree to Keep Producing Joint Content During Divorce
-
Freedom 250 Winner Kirkwood Jokes Against IndyCar Return to Washington
-
TMZ Poll Invites Readers to Weigh Week’s Celebrity and Political Stories
-
Police Report Details Famous Dex Domestic Battery Allegations
-
Court Dispute Features Alleged Racist Texts Attributed to Milo Yiannopoulos
-
Jerusalem Police Operation Uncovers Second Temple-Era Burial Cave
-
Michelle Obama Says She Welcomes Life After Active Parenting Years
-
Sabalenka Defends Basketball-Inspired Nike Kit at US Open
-
College Values Debate Puts Harvard and Columbia Under Parental Scrutiny
-
KFF Journalists Address Measles, Vaccines, Food Recalls and Health Policy
-
Technology Companies Warn Organizations Have Months to Prepare for AI Cyberattacks
-
Running a Local Language Model Offers Privacy With Hardware Trade-Offs
-
Study Finds Psilocybin Makes Brain Activity More Responsive to Immediate Experience
-
Trump Call Briefly Interrupts Nvidia Company Meeting
-
KFF Health News Minute Tracks Weekly US Healthcare Developments
-
RoboSense Robotics Revenue Expands as New Sensor and Joint Products Near Production
-
China Auto Exports Surge as Industry Moves Toward Overseas Production
-
Nepal Flood Zone Faces New Threat From Landslide-Formed Lakes
-
Sunwoda First-Half Revenue Reaches Record as Battery Shipments Accelerate
-
US Accelerates Review for 30-Year Trans-Alaska Pipeline Renewal
-
Week 0 Betting Promotions Span Sportsbooks and Prediction Markets
-
Russian Strike in Kyiv Region Kills at Least 27 and Forces Evacuations
-
Notre Dame, LSU and Utah Selected at Different Levels of College Football Title Market
-
Opinion Debate Revisits Privilege and the Meaning of Noblesse Oblige
-
At least 37 dead after Russian strike on depot near Kyiv
-
Nepalis cling to hope for missing, three days after disaster
-
Clashes in Niamey after troops attempt to storm presidential palace
-
Norway mourns passing of King Harald as son King Haakon VIII ascends throne
-
At least 27 dead after Russian strike on depot near Kyiv
-
Norris extends McLaren stay until 2030
-
Tamil Nadu Assembly Clash Continues Over 10.5% Vanniyar Reservation
-
Fatal Sign Collapse Ends Big Church Festival Early
-
Vijay Orders More Rehabilitation Opportunities During Puzhal Prison Visit
Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Piper Sandler's 37th Annual Healthcare Conference, on Tuesday, December 2nd at 11:00am ET
A live webcast of each of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
W.Stewart--AT